Initiate Wound Healing With Noncontact, Low-Frequency Ultrasound Therapy
For patients who suffer from either acute or chronic wounds, any delay in healing increases risk to patients’ overall health and quality of life. It also places a significant burden on the healthcare system. Typical wound management protocols can be successful in some cases. However, depending upon wound-specific characteristics, chronicity, and comorbidities, standard protocols leave many other patients with chronic wounds that do not heal. By choosing an energy-first approach and making CyteMed’s UltraMIST System your first-line treatment for advanced wounds, you give your patients a high chance for improvement and ultimately, heal their wounds.
What the Evidence-Based UltraMIST System Is
The UltraMIST System delivers low-frequency ultrasound to the treatment site using a noncontact fluid (e.g., saline). MIST Systems produce a low energy ultrasound-generated mist used to promote wound healing through wound
cleansing and maintenance debridement by the removal of fibrin, yellow slough, tissue exudates, and bacteria.
Administered by healthcare professionals to thousands of patients for more than a decade and supported by a vast array of clinical evidence, the painless, low-frequency and noncontact ultrasound acoustic wave therapy delivered via the UltraMIST System promotes healing. The MOA includes control of inflammation, augmentation of local tissue perfusion, wound bacteria and bacterial biofilm reduction, increased angiogenesis, and more.
Benefits for Advanced Wound Care
By activating the body’s normal regeneration process, the UltraMIST System offers important wound healing advantages. First, it reduces barriers to healing by reducing bacterial overgrowth, disrupting bacterial biofilms, and controlling inflammation.
At the same time, UltraMIST System therapy promotes healing through vasodilation and by accelerating angiogenesis. A meta-analysis of clinical evidence in cases including diabetic foot, ischemic, neuropathic, venous, multifactorial, pressure, surgical, and traumatic ulcers shows that the rate of wound closure increased from 24% with standard care to 42% with UltraMIST use over a 12-week interval.
To accelerate wound healing even more, in between the UltraMIST System treatments, other standard or advanced wound therapies may be incorporated into the treatment plan — at the discretion of the wound care professional.
The result? Faster relief and better quality of life for your patients with less expenditure of time and resources on costly treatments that don’t work. These savings make the UltraMIST System a financially viable solution for the patient, the provider, and the healthcare system as a whole.
All Typical and Atypical Nonhealing Wounds* Including but Not Limited to:
- Diabetic Foot Ulcers
- Pressure Ulcers
- Venous Leg Ulcers
- Deep Tissue Pressure Injuries
- Surgical Wounds
*Exceptions: Cancerous lesions, over-pregnant uterus, over-implanted device